THRD RSI Chart
Last 7 days
16.4%
Last 30 days
22.8%
Last 90 days
37.5%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 09, 2024 | holles natalie c. | acquired | 84,932 | 4.2 | 20,222 | ceo |
May 09, 2024 | holles natalie c. | sold | -246,300 | 12.1798 | -20,222 | ceo |
Apr 11, 2024 | holles natalie c. | acquired | 56,943 | 4.2 | 13,558 | ceo |
Apr 11, 2024 | holles natalie c. | sold | -165,214 | 12.1857 | -13,558 | ceo |
Apr 04, 2024 | person julie | acquired | 4,649 | 4.2 | 1,107 | chief administrative officer |
Apr 04, 2024 | person julie | sold | -11,070 | 10.00 | -1,107 | chief administrative officer |
Dec 05, 2023 | conner edward r. | sold | -48,062 | 10.0339 | -4,790 | chief medical officer |
Dec 05, 2023 | conner edward r. | acquired | 20,118 | 4.2 | 4,790 | chief medical officer |
Dec 05, 2023 | person julie | acquired | 54,024 | 4.2 | 12,863 | chief administrative officer |
Dec 05, 2023 | person julie | sold | -132,484 | 10.2996 | -12,863 | chief administrative officer |
Which funds bought or sold THRD recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | added | 81.4 | 74,697 | 207,840 | -% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -38.9 | -16,677 | 18,493 | -% |
May 15, 2024 | OCCUDO QUANTITATIVE STRATEGIES LP | new | - | 134,284 | 134,284 | 0.02% |
May 15, 2024 | Royal Bank of Canada | reduced | -92.64 | -63,000 | 4,000 | -% |
May 15, 2024 | COMMODORE CAPITAL LP | reduced | -11.56 | -3,705,130 | 11,800,000 | 0.79% |
May 15, 2024 | HSBC HOLDINGS PLC | new | - | 113,063 | 113,063 | -% |
May 15, 2024 | BRAIDWELL LP | sold off | -100 | -14,436,700 | - | -% |
May 15, 2024 | MORGAN STANLEY | reduced | -32.38 | -882,675 | 1,228,510 | -% |
May 15, 2024 | BARCLAYS PLC | reduced | -40.04 | -142,000 | 152,000 | -% |
May 15, 2024 | WELLINGTON MANAGEMENT GROUP LLP | new | - | 794,943 | 794,943 | -% |
Unveiling Third Harmonic Bio Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Third Harmonic Bio Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Third Harmonic Bio Inc News
Balance Sheet | |||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2021Q4 |
Assets | -2.6% | 271 | 278 | 282 | 286 | 291 | 299 | 305 | 129 |
Current Assets | -2.5% | 266 | 272 | 277 | 280 | 286 | 293 | 304 | 129 |
Cash Equivalents | -2.3% | 263 | 269 | 274 | 278 | 282 | 289 | 300 | 128 |
Net PPE | -7.1% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - |
Liabilities | -18.6% | 7.00 | 9.00 | 9.00 | 8.00 | 9.00 | 10.00 | 6.00 | 6.00 |
Current Liabilities | -25.8% | 4.00 | 5.00 | 6.00 | 4.00 | 5.00 | 6.00 | 6.00 | 6.00 |
Shareholder's Equity | -2.1% | 264 | 269 | 273 | 278 | 283 | 289 | 298 | -46.71 |
Retained Earnings | -6.9% | -122 | -114 | -107 | -100 | -92.50 | -83.40 | -71.90 | -48.24 |
Additional Paid-In Capital | 0.6% | 386 | 383 | 380 | 378 | 375 | 372 | 370 | 2.00 |
Shares Outstanding | 1.5% | 41.00 | 40.00 | 40.00 | 40.00 | 39.00 | 39.00 | 9.00 | 4.00 |
Float | - | - | - | - | 86.00 | - | - | 388 | - |
Cashflow (Quarterly) | ||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 |
Cashflow From Operations | -12.2% | -6,293 | -5,607 | -4,183 | -3,960 | -6,675 | -9,287 | -10,778 | -6,739 | -8,113 | - | - |
Share Based Compensation | 26.4% | 2,223 | 1,759 | 2,291 | 2,845 | 2,682 | 2,133 | 1,009 | 1,159 | 450 | - | - |
Cashflow From Investing | 100.0% | - | -1.00 | - | -168 | - | -36.00 | - | - | - | - | - |
Cashflow From Financing | -93.9% | 49.00 | 798 | -57.00 | 58.00 | - | -875 | 197,563 | -697 | - | - | - |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Operating expenses: | ||
Research and development | $ 6,226 | $ 6,737 |
General and administrative | 5,064 | 5,251 |
Total operating expenses | 11,290 | 11,988 |
Loss from operations | 11,290 | 11,988 |
Other income, net: | ||
Interest income | (3,433) | (2,905) |
Other (income) expense | (1) | 2 |
Total other income, net | (3,434) | (2,903) |
Net loss | $ 7,856 | $ 9,085 |
Net loss per share of common stock, basic | $ 0.2 | $ 0.23 |
Net loss per share of common stock, diluted | $ 0.2 | $ 0.23 |
Weighted-average number of common stock outstanding, basic | 40,213,158 | 39,438,572 |
Weighted-average number of common stock outstanding, diluted | 40,213,158 | 39,438,572 |
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 262,826 | $ 269,070 |
Prepaid expenses and other current assets | 2,771 | 3,376 |
Total current assets | 265,597 | 272,446 |
Restricted cash | 453 | 453 |
Property and equipment, net | 157 | 169 |
Right of use asset | 3,589 | 3,763 |
Other assets, noncurrent | 725 | 880 |
Total assets | 270,521 | 277,711 |
Current liabilities: | ||
Accounts payable | 945 | 1,838 |
Accrued expenses and other current liabilities | 2,300 | 2,835 |
Operating lease liability, current | 773 | 745 |
Total current liabilities | 4,018 | 5,418 |
Operating lease liability, noncurrent | 3,002 | 3,208 |
Total liabilities | 7,020 | 8,626 |
Commitments and contingencies (Note 11) | ||
Stockholders' equity: | ||
Common stock, $0.0001 par value, 500,000,000 shares authorized at December 31, 2023 and March 31, 2024; 40,104,937 and 40,252,868 shares issued and outstanding at December 31, 2023 and March 31, 2024, respectively | 4 | 4 |
Additional paid-in capital | 385,573 | 383,301 |
Accumulated deficit | (122,076) | (114,220) |
Total stockholders' equity | 263,501 | 269,085 |
Total liabilities and stockholders' equity | $ 270,521 | $ 277,711 |